IL92961A0 - Anti-inflammatory 1-heteroarylox-indole-3-carboxamides - Google Patents

Anti-inflammatory 1-heteroarylox-indole-3-carboxamides

Info

Publication number
IL92961A0
IL92961A0 IL92961A IL9296190A IL92961A0 IL 92961 A0 IL92961 A0 IL 92961A0 IL 92961 A IL92961 A IL 92961A IL 9296190 A IL9296190 A IL 9296190A IL 92961 A0 IL92961 A0 IL 92961A0
Authority
IL
Israel
Prior art keywords
furyl
thienyl
alkyl
indole
heteroarylox
Prior art date
Application number
IL92961A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL92961A0 publication Critical patent/IL92961A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
IL92961A 1989-01-10 1990-01-03 Anti-inflammatory 1-heteroarylox-indole-3-carboxamides IL92961A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/000080 WO1990008146A1 (fr) 1989-01-10 1989-01-10 1-heteroarylindoxyle-3-carboxamides anti-inflammatoires

Publications (1)

Publication Number Publication Date
IL92961A0 true IL92961A0 (en) 1990-09-17

Family

ID=22214773

Family Applications (1)

Application Number Title Priority Date Filing Date
IL92961A IL92961A0 (en) 1989-01-10 1990-01-03 Anti-inflammatory 1-heteroarylox-indole-3-carboxamides

Country Status (20)

Country Link
US (1) US5128352A (fr)
EP (1) EP0378357B1 (fr)
JP (1) JPH0678337B2 (fr)
KR (1) KR920006784B1 (fr)
AT (1) ATE100096T1 (fr)
AU (1) AU616090B2 (fr)
CA (1) CA2007651C (fr)
DE (1) DE69005833T2 (fr)
DK (1) DK0378357T3 (fr)
ES (1) ES2062318T3 (fr)
FI (1) FI94247C (fr)
HU (1) HU217072B (fr)
IE (1) IE61796B1 (fr)
IL (1) IL92961A0 (fr)
MY (1) MY106261A (fr)
NO (1) NO178193C (fr)
NZ (1) NZ232038A (fr)
PT (1) PT92801B (fr)
WO (1) WO1990008146A1 (fr)
ZA (1) ZA90140B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2247604T3 (es) * 1995-06-12 2006-03-01 G.D. SEARLE & CO. Composiciones que comprenden un inhibidor de ciclooxigenasa-2 y un inhibidor de 5-lipoxigenasa.
US10351532B2 (en) 2014-12-29 2019-07-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
US4176191A (en) * 1977-09-06 1979-11-27 Abbott Laboratories Aminomethylene oxindoles
US4476307A (en) * 1982-09-20 1984-10-09 Pfizer Inc. Heteroylidene indolone compounds
DE3582890D1 (de) * 1984-02-07 1991-06-20 Pfizer 2-oxindolzwischenprodukte.
HU203350B (en) * 1984-08-24 1991-07-29 Pfizer Process for producing antiinflammatory tricyclic oxindole derivatives
US4644005A (en) * 1984-10-31 1987-02-17 Pfizer Inc. Oxindole antiinflammatory agents
US4686224A (en) * 1984-10-31 1987-08-11 Pfizer Inc. Oxindole antiinflammatory agents
US4791129A (en) * 1987-01-20 1988-12-13 Pfizer Inc. 1,3-dicarboxamidooxindoles as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
NO912696L (no) 1991-07-09
US5128352A (en) 1992-07-07
FI94247C (fi) 1995-08-10
JPH0678337B2 (ja) 1994-10-05
FI913325A0 (fi) 1991-07-09
EP0378357A1 (fr) 1990-07-18
PT92801A (pt) 1990-07-31
KR900011763A (ko) 1990-08-02
WO1990008146A1 (fr) 1990-07-26
NO178193B (no) 1995-10-30
KR920006784B1 (ko) 1992-08-17
JPH02247174A (ja) 1990-10-02
DE69005833D1 (de) 1994-02-24
HUT58084A (en) 1992-01-28
MY106261A (en) 1995-04-29
FI94247B (fi) 1995-04-28
NO912696D0 (no) 1991-07-09
AU616090B2 (en) 1991-10-17
NZ232038A (en) 1991-06-25
HU217072B (hu) 1999-11-29
ES2062318T3 (es) 1994-12-16
DK0378357T3 (da) 1994-02-14
PT92801B (pt) 1995-12-29
ZA90140B (en) 1991-08-28
ATE100096T1 (de) 1994-01-15
DE69005833T2 (de) 1994-04-28
IE900074L (en) 1990-07-10
EP0378357B1 (fr) 1994-01-12
CA2007651C (fr) 1997-08-19
IE61796B1 (en) 1994-11-30
AU4781790A (en) 1990-07-19
NO178193C (no) 1996-02-07
CA2007651A1 (fr) 1991-07-12

Similar Documents

Publication Publication Date Title
CY1110581T1 (el) Η χρηση της δουλοξετινης για τη θεραπεια της ινομυαλγιας
ATE431347T1 (de) Neue heterocyclylmethyl-substituierte pyrazolderivate und ihre verwendung in der behandlung von herz-kreislauf-erkrankungen
TW344661B (en) Pharmaceutical composition for treatment of incontinence
NO995850L (no) 8-azabisyklo(3.2.1)okt-2-en- og -oktanderivater som cholinerge ligander i nikotin-ACh-reseptorer
NZ514037A (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders
DE60026404D1 (de) Verfahren zur Herstellung von Benzothiophen-Derivaten
CA2521732A1 (fr) Acetamides de 3-cyanothiophene substitues en tant qu'antagonistes de recepteur de glucagon
CA2238410A1 (fr) Nouveaux derives d'indol-2,3-dion-3-oxime
KR940006580A (ko) 질병을 치료하기 위한 치환된 사이클로헥산 유도체
CA2084163A1 (fr) Substance antagoniste de l'endotheline
CA2443868A1 (fr) Derives de 1,3,8-triazaspiro[4.5]decan-4-one utiles dans le traitement de troubles induits par le recepteur orl-1
IL92961A0 (en) Anti-inflammatory 1-heteroarylox-indole-3-carboxamides
BR9503775A (pt) Compostos e composição farmacêutica útil como um agente analgésico antiinflamatório diurético ou neuroprotetor
ATE302779T1 (de) Dihydro-2,3-benzodiazepinderivate
FI913324A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1-heteroaryyli-3-asyyli-2-oksindolijohdannaisten valmistamiseksi
KR880008999A (ko) 3-아릴-5-알킬티오-4h-1,2,4-트리아졸
ES8302006A1 (es) Procedimiento para la preparacion de nuevas cefalosporinas .

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees